|
Market Closed -
Nasdaq
16:00:00 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 14.39 USD | +7.31% |
|
+6.51% | +265.23% |
| 09-20 | Turn Therapeutics Inc.(NasdaqGM:TTRX) added to S&P TMI Index | CI |
| 09-09 | Turn Therapeutics Inc. Announces Appointment of Robert R. Redfield as Chief Scientific Officer | CI |
| Market Cap | 429M 377M 358M 323M 609M 41.1B 616M 4.28B 1.65B 21.01B 1.61B 1.57B 67.36B | P/E 2026 * |
-31.3x | P/E 2027 * | -32x |
|---|---|---|---|---|---|
| Enterprise Value | 429M 377M 358M 323M 609M 41.1B 616M 4.28B 1.65B 21.01B 1.61B 1.57B 67.36B | EV / Sales 2026 * |
1,715x | EV / Sales 2027 * | 171x |
| Free-Float |
45.25% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TTRX | Delayed | |
CBOE
| TTRX | Real-time |
| 1 day | +7.31% | ||
| 1 week | +6.51% | ||
| 1 month | +49.90% | ||
| 3 months | +97.12% | ||
| 6 months | +349.69% | ||
| Current year | +265.23% |
| 1 week | 12.28 |  | 14.63 |
| 1 month | 9 | | 16.45 |
| Current year | 3.01 | | 16.45 |
| 1 year | 2.57 | | 26.5 |
| 3 years | 2.57 | | 26.5 |
| 5 years | 2.57 | | 26.5 |
| 10 years | 2.57 | | 26.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bradley Burnam
CEO | Chief Executive Officer | 48 | 2015-01-05 |
Zuraiz Chaudhary
DFI | Director of Finance/CFO | 31 | 2025-04-30 |
Stephen Hahn
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Bradley Burnam
CHM | Chairman | 48 | - |
| Director/Board Member | 46 | 2018-09-30 | |
Andrew Gengos
BRD | Director/Board Member | 61 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/28/26 | Don | Chief Executive Officer | -1,200,000 | 4.0285% | ||
| 4/2/26 | Don | Chief Executive Officer | 300,000 | 1.0188% | ||
| 4/2/26 | Don | Director | 300,000 | 1.0188% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.31% | +6.51% | - | - | 399M | |
| +4.16% | -0.36% | +49.37% | +94.17% | 71.53B | |
| -0.19% | +1.32% | +37.20% | +83.85% | 60.12B | |
| -1.51% | +2.39% | +9.10% | +35.15% | 48.85B | |
| -0.05% | +0.37% | +41.54% | +36.65% | 44.28B | |
| +0.38% | +7.61% | +339.53% | +641.55% | 43.83B | |
| +0.18% | +0.26% | +7.41% | +103.45% | 41.53B | |
| -0.67% | +0.17% | +7.60% | +46.37% | 30.13B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 27.98B | |
| -1.29% | -3.55% | -20.74% | +352.04% | 25.25B | |
| Average | +1.31% | -0.17% | +56.42% | +157.33% | 39.39B | |
| Weighted average by Cap. | +0.81% | +1.36% | +60.93% | +148.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 250K 220K 209K 188K 355K 23.97M 360K 2.5M 960K 12.25M 939K 918K 39.29M | 2.5M 2.2M 2.09M 1.88M 3.55M 240M 3.59M 24.96M 9.6M 123M 9.39M 9.18M 393M |
| Net income | -15.5M -13.65M -12.93M -11.68M -22M -1.49B -22.29M -155M -59.54M -760M -58.2M -56.93M -2.44B | -23M -20.25M -19.19M -17.32M -32.65M -2.21B -33.07M -230M -88.35M -1.13B -86.36M -84.48M -3.61B |
| Net Debt | - | - |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | US$14.39 | +7.31% | 88,715 |
| 26-09-29 | US$13.41 | +2.84% | 79,533 |
| 26-09-28 | US$13.04 | +4.40% | 76,732 |
| 26-09-25 | US$12.49 | -5.81% | 89,953 |
| 26-09-24 | US$13.26 | -1.85% | 244,962 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
14.39USD
Average target price
25.00USD
Spread / Average Target
+73.73%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TTRX Stock
Select your edition
All financial news and data tailored to specific country editions
